Conditions: ADHD
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 336
Healthy volunteers: no

Brief summary:
The main aim of this study is to see if giving LDX to children and adolescents aged 6-17 years with ADHD decreases symptoms of ADHD.

Detailed description:

Arms:
arm 1: Overencapsulated LDX 30, 50, or 70mg arm 2: Overencapsulated Concerta 18, 36, or 54mg arm 3: Overencapsulated Placebo

Interventions: intervention 1: Lisdexamfetamine Dimesylate (LDX) intervention 2: Methylphenidate Hydrochloride intervention 3: Placebo
Intervention descriptions: intervention 1: 30, 50 or 70mg capsule once per day (Overencapsulated) intervention 2: 18, 36, or 54mg tablet one per day (Overencapsulated) intervention 3: Placebo capsule once per day (Overencapsulated)

Protocol document: